Based on previous preclinical results, Elan and Wyeth initiated a clinical trial of active immunization with aggregated synthetic A β1−42 peptide/QS21 adjuvant against A β in patients with AD in 2001.
The definition of active/best supportive care (ASC/BSC) is adapted from the description of supportive care in a key trial of active chemotherapy vs BSC in the second-line setting (Cunningham et al, 1998).
A randomized trial of active management of labour among women with prolonged latent phase labour, including oxytocin augmentation, with standardized protocols for other aspects of labour management may answer this question.
The limitations of this study included the patient population, which was recruited for a clinical trial of active PsA and may not be completely representative of the wider PsA population.
The limitations of this study include the patient population, which was recruited for a clinical trial of active axSpA and therefore may not be completely representative of the wider axSpA population.
Our findings demonstrated a greater improvement when compared with Measuring hand hygiene at room entry and exit, a European trial of active surveillance for antimicrobial-resistant bacteria reported in 2014 an improvement in mean hand hygiene compliance from 52 77 % [ 18].
Only a few studies showing feasibility of the technique have been published (Table 3) [25,80–82], although a randomised controlled trial of active surveillance versus hemi- or subtotal PDT therapy has almost completed recruitment (NCT01310894).
A randomized controlled trial of active management of labor conducted in Auckland, New Zealand, reported that the practice was related to reduction of labor time and a postpartum report of longer labor than expected was strongly associated with reduction of maternal satisfaction [ 21, 22].
Performance of the RDQ after translation into Swedish and Norwegian was evaluated in 439 patients with presumed GERD in a randomized, double-blind trial of active treatment with a proton pump inhibitor.
In a pilot randomized clinical trial of active stellate ganglion blockade (SGB) versus sham control, SGB significantly reduced the frequency of reported moderate to severe vasomotor symptoms (VMS) and the frequency of physiologic VMS measured using ambulatory skin conductance monitors.
